ADVERTISEMENT
What Sun Pharma’s Troubles Mean For The Stock
This is what fund managers and analysts had to say about Sun Pharma saga.
21 Jan 2019, 08:49 PM IST
Shares of Sun Pharmaceuticals Industries Ltd. tumbled as much as 13.21 percent, the most in nearly 20 months, as anxious institutional investors sold the scrip after a report revealed excerpts about a whistleblower’s complaint against controlling shareholder Dilip Shanghvi.India’s largest drugmaker’s corporate governance concerns were back in the spotlight with Moneylife publishing part of the complaint alleging irregularities by the...
I’m already a Subscriber Sign In
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits
Choose a plan
Renews automatically. Cancel anytime.
As a Subscriber you get
Full Access to
NDTV Profit App
Exclusives
Premium Stories
Access to
Stories
Curated
Newsletters
20,000+
Research Reports
Priority Pass
to Special Events
Minimal Ad
Experience
Members-Only
Rewards
Still Not convinced ? Know More
Get live Stock market updates, Business news, Today’s latest news, Trending stories, and Videos on NDTV Profit.
ADVERTISEMENT